Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma
Peter E ClarkVanderbilt University Medical Center, Nashville, Tennessee, USAAbstract: Advanced renal cell carcinoma (RCC) remains a challenging, major health problem. Recent advances in understanding the fundamental biology underlying one form of RCC, ie, clear cell (or conventional) RCC, have opene...
Guardado en:
Autor principal: | Peter E Clark |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3bbb7ac2bde54dc1b115219024a4f576 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeted therapies in the management of renal cell carcinoma: role of bevacizumab
por: Bernard Escudier, et al.
Publicado: (2008) -
Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study
por: Mustafa Erman, et al.
Publicado: (2021) -
Prolonged Survival Using First-Line Pazopanib in a Filipino Male with Renal Cell Carcinoma and Brain Metastasis: A Case Report
por: Christianne V. Mojica, et al.
Publicado: (2021) -
Critical appraisal of axitinib in the treatment of advanced renal cell carcinoma
por: Ansari J, et al.
Publicado: (2013) -
Gemcitabine-loaded liposomes: rationale, potentialities and future perspectives
por: Federico C, et al.
Publicado: (2012)